Lombard Odier Asset Management (USA)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-135,746	Closed	-$1.67M	–	209
2015 Q4	$1.67M	Buy	135,746 +5,432	+4%	+$72.5K	0.16%	123
2015 Q3	$1.9M	Sell	130,314 -146,520	-53%	-$2.53M	0.17%	143
2015 Q2	$5.4M	Buy	+276,834	New	+$5.34M	0.38%	89
2015 Q1	–	Sell	-50,144	Closed	-$1.18M	–	261
2014 Q4	$1.18M	Buy	+50,144	New	+$1.16M	0.08%	155

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s CTIC Position: Q1 2016 in Review

Lombard Odier Asset Management (USA) sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2016, closing a stake of 135,746 shares — an estimated $1.67M sold.

Lombard Odier Asset Management (USA) first reported a position in CTIC in Q4 2014 and held it in 4 quarters. The position peaked at $5.4M in Q2 2015. 80 funds tracked by Wall St. Rank hold CTIC as of Q1 2016.

Lombard Odier Asset Management (USA) reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2016 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 135,746 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2016, an estimated $1.67M.
Lombard Odier Asset Management (USA) first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2014 and held it in 4 quarters.
Lombard Odier Asset Management (USA)'s CTI BioPharma Corp. (DE) Common Stock position peaked at $5.4M in Q2 2015.
80 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2016, filed 16 May 2016.